Skip to content

GREENVEIL

  • industrial
  • pharma

Lamotrigine

CAS 84057-84-1

Lamotrigine chemical structure

Concern score

Not assessed — no hazard data yet.

Lamotrigine in plain language

What it is

Also known as 1,2,4-TRIAZINE-3,5-DIAMINE, 6-(2,3-DICHLOROPHENYL) · 3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine · 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine · 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine · Bw 430C · BW430C

Show all 19 names

Epilepax · Gw 273293 · Lamictal · Lamictal Cd · Lamictal ODT · Lamictal XR · Lamidus · Lamitrin · Lamotirigine · Lamotrigina · Lamotrigine ER · Lamotriginum · Subvenite

What it does

We don't have a plain-language description for Lamotrigine yet.

Recorded functional uses: Pharmaceutical

Is it a concern?
We haven't assessed a concern score for this ingredient yet.

Regulation

No restrictions found. Lamotrigine appears in these published regulatory listings.

  • In marketed US drugs

Recorded in these product areas

  • Found in consumer products
  • Industrial
  • USEPAcommercial use observedEPA CPDat observed this chemical in 0 composition records across product categories including unclassified products. EPA CPDat classifies this chemical for functional uses including Pharmaceutical.
    • EPA CPDat observed this chemical in 0 composition records across product categories including unclassified products. EPA CPDat classifies this chemical for functional uses including Pharmaceutical.Source →
  • USFDAmarketed drug occurrenceFDA NDC lists this ingredient in 275 active drug products and 280 total products.
    • FDA NDC lists this ingredient in 275 active drug products and 280 total products.Source →
  • USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as chemical.
    • openFDA substance registry classifies this ingredient as chemical.Source →

Evidence & sources

No graded research studies for Lamotrigine yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.

6 data sources

Where this comes from

  • EPA Chemical and Products Database

    exposure · updated April 2015

    Open →

  • EPA DSSTox Identifiers

    chemistry · updated 2025-12-29

    Open →

  • FDA National Drug Code Directory

    regulatory · updated 2027-12-31

    Open →

  • FDA GSRS UNII

    registry · updated 2026-02-26

    Open →

  • openFDA Substance

    registry · updated 2026-05-24

    Open →

  • PubChem Live Enrichment

    chemistry · updated 2026-05-17

    Open →
Reference links (2)
Openfda substance

clinicalkey.com

Read →
Openfda substance

accessdata.fda.gov

Read →

Suitability

Context-specific fit derived from published classifications and the current ingredient evidence profile.

Fragrance avoidance

Nothing to weigh for this context yet.

No signal in this context

We have no published hazard signal for this ingredient, so we cannot say how it behaves in this context — that is missing evidence, not a clean result.

Where it has been recorded

How often FDA National Drug Code directory has listed Lamotrigine in a product composition. These are source records, not Greenveil catalog products.

Source records

280

Typical roles

Pharmaceutical
See products using Lamotrigine →